1. Home
  2. MNMD vs PFIS Comparison

MNMD vs PFIS Comparison

Compare MNMD & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mind Medicine (MindMed) Inc.

MNMD

Mind Medicine (MindMed) Inc.

HOLD

Current Price

$12.61

Market Cap

960.2M

Sector

Health Care

ML Signal

HOLD

Logo Peoples Financial Services Corp.

PFIS

Peoples Financial Services Corp.

HOLD

Current Price

$52.49

Market Cap

501.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNMD
PFIS
Founded
2019
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
960.2M
501.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MNMD
PFIS
Price
$12.61
$52.49
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$25.78
N/A
AVG Volume (30 Days)
1.5M
25.2K
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
4.69%
EPS Growth
N/A
582.67
EPS
N/A
5.29
Revenue
N/A
$182,622,000.00
Revenue This Year
N/A
$68.41
Revenue Next Year
N/A
$4.87
P/E Ratio
N/A
$9.94
Revenue Growth
N/A
89.84
52 Week Low
$4.70
$38.90
52 Week High
$14.43
$57.00

Technical Indicators

Market Signals
Indicator
MNMD
PFIS
Relative Strength Index (RSI) 55.67 69.26
Support Level $12.19 $49.07
Resistance Level $13.45 $50.62
Average True Range (ATR) 0.70 1.04
MACD 0.08 0.38
Stochastic Oscillator 72.07 98.03

Price Performance

Historical Comparison
MNMD
PFIS

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About PFIS Peoples Financial Services Corp.

Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.

Share on Social Networks: